Bespoke Extracts (BSPK) Return on Capital Employed Growth (1y) (2013 - 2025)
Bespoke Extracts (BSPK) Return on Capital Employed Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,195.00 |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | -3,834.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,834.00 |
| Jun 30, 2025 | -2,281.00 |
| Mar 31, 2025 | -3,454.00 |
| Dec 31, 2024 | -7,884.00 |
| Sep 30, 2024 | -33,718.00 |
| Jun 30, 2024 | -90,804.00 |
| Mar 31, 2024 | -29,933.00 |
| Dec 31, 2023 | -63,663.00 |
| Sep 30, 2023 | -199,823.00 |
| Jun 30, 2023 | 45,422.00 |
| Mar 31, 2023 | -263,234.00 |
| Nov 30, 2021 | -540,872.00 |
| May 31, 2021 | 341,464.00 |
| Feb 28, 2021 | 263,437.00 |
| Nov 30, 2020 | -142,915.00 |
| May 31, 2020 | 13,277.00 |
| Feb 29, 2020 | 45,633.00 |
| Nov 30, 2019 | 192,612.00 |
| Aug 31, 2019 | 413,937.00 |
| May 31, 2019 | -282,487.00 |